Ubs Asset Management Americas Inc Galapagos Nv Transaction History

Ubs Asset Management Americas Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 14, 2020	SELL	$146.12 - $215.82 $2.29 Million - $3.39 Million	-15,685 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$130.44 - $187.64 $149,353 - $214,847	1,145 Added 7.87%	15,685 $2.39 Million
Q2 2019 Aug 15, 2019	BUY	$111.45 - $128.93 $259,344 - $300,020	2,327 Added 19.05%	14,540 $0
Q1 2019 May 14, 2019	BUY	$89.61 - $117.78 $99,287 - $130,500	1,108 Added 9.98%	12,213 $0
Q4 2018 Feb 13, 2019	BUY	$87.81 - $110.65 $975,130 - $1.23 Million	11,105 New	11,105 $1.02 Million

12.3M

69.1K

42.7K

Ticker GLPG
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,835,500
Market Cap $1.9B
Description
Galapagos NV, an integrated biopharmaceutical company, engages in the discovery, development, and commercialization of various medicines for high unmet medical need. Its pipeline products include filgotinib, a JAK1 inhibitor that is in various phases of clinical trials for the treatment of rheumatoid arthritis, Crohn's disease, ulcerative coliti...

Get notified when there are updates to the investment portfolio of Ubs Asset Management Americas Inc, based on Form 13F filings with the SEC.

Stay updated on Ubs Asset Management Americas Inc with notifications on news.